implantation with an autologous human palatal mucosa substitute made of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT).
FIB-BIO-2023-03
Phase 2 other active
Quick answer
implantation with an autologous human palatal mucosa substitute made of nanostructured fibrin-agarose generated by tissue engineering (BIOCLEFT). for Cleft Lip and Palate is a Phase 2 program (other) at Design Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Design Therapeutics
- Indication
- Cleft Lip and Palate
- Phase
- Phase 2
- Modality
- other
- Status
- active